National Framework Agreement for Transperineal Prostate Biopsy System

Procurement reference

F/077/TAS/25/SB

Procurement description

Commercial Procurement Services (CPS) wishes to award a framework agreement or agreements for the provision of Transperineal Prostate Biopsy Systems which will allow Participating Authorities to procure a system from a multi-supplier framework.

The proposed framework will allow Participating Authorities to procure these goods in a legally compliant manner, with the assurance that Suppliers have met rigorous criteria.

Main category

Goods

Delivery regions

• UK - United Kingdom

Total value (estimated, excluding VAT)

19800000.00 GBP to 19800000.00GBP

Contract dates (estimated)

11 October 2025, 00:00AM to 10 October 2027, 23:59PM

Extension end date (if all the extensions are used): 10 October 2033

Is a framework being established?

Yes

Is this an open framework scheme?

Yes

COUNTESS OF CHESTER HOSPITAL NHS FOUNDATION TRUST

Procedure type

Open procedure

Is the total value above threshold?

Above threshold

Trade agreements

Government Procurement Agreement (GPA)

Further information about fees

The Framework Fees will be in the form of a Gain Share Charge. The Gain Share Charges will be calculated at a rate of 1.5% of the turnover of each Call-off Contract awarded via a Framework Agreement. The Gain Share Charge will be paid by the Framework Supplier to the Framework Host for the duration of each Call-off Contract. Call-off Contracts may exceed a Framework Agreement Expiry Date and in such cases the Gain Share charges will continue to be paid until the Call-off Contract expiry date.

Percentage fee charged to suppliers

1.5000%

Type of framework

Open

Open framework scheme end date (estimated)

10 October 2033, 23:59PM

Award method when using the framework

With and without reopening competition

Contracting authority locations

• UK

Contracting authorities that may use the framework

To provide bidders with information on potential users of the Framework, a list of eligible users is provided within the ITT pack and is attached to this notice.

Framework operation description

Call off contracts may be awarded with or without further competition.

A detailed explanation of the call off award process and evaluation criteria to be used as part of this process is available in Section 6 of Document 1 of the ITT Pack.

CPV classifications

• 33141323 - Biopsy needles

Delivery regions

• UK - United Kingdom

Lot value (estimated)

19800000.00 GBP Excluding VAT

23760000.00 GBP Including VAT

Sustainability

Small and medium-sized enterprises (SME)

Contract start date (estimated)

11 October 2025, 00:00AM

Contract end date (estimated)

10 October 2027, 23:59PM

Extension end date (estimated)

10 October 2033, 23:59PM

Can the contract be extended?

Yes

Description of extensions

This is Framework 1 of an Open Framework.

The Term of the Open Framework shall be 8 years from the Commencement Date. It is intended that the Open Framework will be reopened every 24 months as the Framework Host deems necessary. At these points, incumbent framework suppliers will have the opportunity to revise their Tender, or they may leave their offer as per their last framework tender submission.

The term of Framework 1 shall be 24 months from the commencement date.

Participation

Award criteria

Tender submission deadline

24 July 2025, 14:00PM

Date of award of contract

08 September 2025, 23:59PM

Submission address and any special instructions

Offers must be written in English and submitted via the Framework Host's e-sourcing portal at https://health-family.force.com/s/Welcome

May tenders be submitted electronically?

Yes

Is this a recurring procurement?

No

Publication date of next tender notice (estimated)

01 July 2027, 23:59PM

Languages that may be used for submission

• English